Selected research
Industry Growth & Trends
Global Microneedle-mediated Drug Delivery Patch Industry Growth and Trends Forecast to 2032
Market perspective
The global Microneedle-mediated Drug Delivery Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Microneedle-mediated Drug Delivery Patch include KINDEVA, Zosano Pharma, Vaxxas, Valeritas, TheraJect, Inc, Nitto, Nanopass Technologies, Microdermics and Lohmann Therapie-Systeme AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Microneedle-mediated Drug Delivery Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Microneedle-mediated Drug Delivery Patch market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microneedle-mediated Drug Delivery Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microneedle-mediated Drug Delivery Patch.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Microneedle-mediated Drug Delivery Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Microneedle-mediated Drug Delivery Patch Market by Company
KINDEVA
Zosano Pharma
Vaxxas
Valeritas
TheraJect, Inc
Nitto
Nanopass Technologies
Microdermics
Lohmann Therapie-Systeme AG
Corium
Becton-Dickinson(BD)Technologies
Microneedle-mediated Drug Delivery Patch Segment by Type
Solid Microneedle Technology
Hollow Microneedle Technology
Dissolving Microneedles Technology
Microneedle-mediated Drug Delivery Patch Segment by Application
Hospital
Retail Pharmacy
Others
Microneedle-mediated Drug Delivery Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle-mediated Drug Delivery Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microneedle-mediated Drug Delivery Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle-mediated Drug Delivery Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microneedle-mediated Drug Delivery Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Microneedle-mediated Drug Delivery Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Microneedle Technology
- Hollow Microneedle Technology
- Dissolving Microneedles Technology
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- KINDEVA
- Zosano Pharma
- Vaxxas
- Valeritas
- TheraJect, Inc
- Nitto
- Nanopass Technologies
- Microdermics
- Lohmann Therapie-Systeme AG
- Corium
- Becton-Dickinson(BD)Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Microneedle-mediated Drug Delivery Patch Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Microneedle-mediated Drug Delivery Patch Sales Estimates and Forecasts (2021-2032)
- 1.3 Microneedle-mediated Drug Delivery Patch Market by Type
- 1.3.1 Solid Microneedle Technology
- 1.3.2 Hollow Microneedle Technology
- 1.3.3 Dissolving Microneedles Technology
- 1.4 Global Microneedle-mediated Drug Delivery Patch Market Size by Type
- 1.4.1 Global Microneedle-mediated Drug Delivery Patch Market Size Overview by Type (2021-2032)
- 1.4.2 Global Microneedle-mediated Drug Delivery Patch Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Microneedle-mediated Drug Delivery Patch Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Microneedle-mediated Drug Delivery Patch Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Microneedle-mediated Drug Delivery Patch Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Microneedle-mediated Drug Delivery Patch Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Microneedle-mediated Drug Delivery Patch Industry Trends
- 2.2 Microneedle-mediated Drug Delivery Patch Industry Drivers
- 2.3 Microneedle-mediated Drug Delivery Patch Industry Opportunities and Challenges
- 2.4 Microneedle-mediated Drug Delivery Patch Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Microneedle-mediated Drug Delivery Patch Revenue (2021-2026)
- 3.2 Global Top Players by Microneedle-mediated Drug Delivery Patch Sales (2021-2026)
- 3.3 Global Top Players by Microneedle-mediated Drug Delivery Patch Price (2021-2026)
- 3.4 Global Microneedle-mediated Drug Delivery Patch Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Microneedle-mediated Drug Delivery Patch Major Company Production Sites & Headquarters
- 3.6 Global Microneedle-mediated Drug Delivery Patch Company, Product Type & Application
- 3.7 Global Microneedle-mediated Drug Delivery Patch Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Microneedle-mediated Drug Delivery Patch Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Microneedle-mediated Drug Delivery Patch Players Market Share by Revenue in 2025
- 3.8.3 2025 Microneedle-mediated Drug Delivery Patch Tier 1, Tier 2, and Tier 3
4 Microneedle-mediated Drug Delivery Patch Regional Status and Outlook
- 4.1 Global Microneedle-mediated Drug Delivery Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Microneedle-mediated Drug Delivery Patch Historic Market Size by Region
- 4.2.1 Global Microneedle-mediated Drug Delivery Patch Sales in Volume by Region (2021-2026)
- 4.2.2 Global Microneedle-mediated Drug Delivery Patch Sales in Value by Region (2021-2026)
- 4.2.3 Global Microneedle-mediated Drug Delivery Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Microneedle-mediated Drug Delivery Patch Forecasted Market Size by Region
- 4.3.1 Global Microneedle-mediated Drug Delivery Patch Sales in Volume by Region (2027-2032)
- 4.3.2 Global Microneedle-mediated Drug Delivery Patch Sales in Value by Region (2027-2032)
- 4.3.3 Global Microneedle-mediated Drug Delivery Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Microneedle-mediated Drug Delivery Patch by Application
- 5.1 Microneedle-mediated Drug Delivery Patch Market by Application
- 5.1.1 Hospital
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Microneedle-mediated Drug Delivery Patch Market Size by Application
- 5.2.1 Global Microneedle-mediated Drug Delivery Patch Market Size Overview by Application (2021-2032)
- 5.2.2 Global Microneedle-mediated Drug Delivery Patch Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Microneedle-mediated Drug Delivery Patch Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Microneedle-mediated Drug Delivery Patch Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Microneedle-mediated Drug Delivery Patch Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Microneedle-mediated Drug Delivery Patch Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 KINDEVA
- 6.1.1 KINDEVA Company Information
- 6.1.2 KINDEVA Business Overview
- 6.1.3 KINDEVA Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 KINDEVA Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.1.5 KINDEVA Recent Developments
- 6.2 Zosano Pharma
- 6.2.1 Zosano Pharma Company Information
- 6.2.2 Zosano Pharma Business Overview
- 6.2.3 Zosano Pharma Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Zosano Pharma Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.2.5 Zosano Pharma Recent Developments
- 6.3 Vaxxas
- 6.3.1 Vaxxas Company Information
- 6.3.2 Vaxxas Business Overview
- 6.3.3 Vaxxas Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Vaxxas Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.3.5 Vaxxas Recent Developments
- 6.4 Valeritas
- 6.4.1 Valeritas Company Information
- 6.4.2 Valeritas Business Overview
- 6.4.3 Valeritas Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Valeritas Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.4.5 Valeritas Recent Developments
- 6.5 TheraJect, Inc
- 6.5.1 TheraJect, Inc Company Information
- 6.5.2 TheraJect, Inc Business Overview
- 6.5.3 TheraJect, Inc Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 TheraJect, Inc Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.5.5 TheraJect, Inc Recent Developments
- 6.6 Nitto
- 6.6.1 Nitto Company Information
- 6.6.2 Nitto Business Overview
- 6.6.3 Nitto Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nitto Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.6.5 Nitto Recent Developments
- 6.7 Nanopass Technologies
- 6.7.1 Nanopass Technologies Company Information
- 6.7.2 Nanopass Technologies Business Overview
- 6.7.3 Nanopass Technologies Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nanopass Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.7.5 Nanopass Technologies Recent Developments
- 6.8 Microdermics
- 6.8.1 Microdermics Company Information
- 6.8.2 Microdermics Business Overview
- 6.8.3 Microdermics Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Microdermics Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.8.5 Microdermics Recent Developments
- 6.9 Lohmann Therapie-Systeme AG
- 6.9.1 Lohmann Therapie-Systeme AG Company Information
- 6.9.2 Lohmann Therapie-Systeme AG Business Overview
- 6.9.3 Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.9.5 Lohmann Therapie-Systeme AG Recent Developments
- 6.10 Corium
- 6.10.1 Corium Company Information
- 6.10.2 Corium Business Overview
- 6.10.3 Corium Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Corium Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.10.5 Corium Recent Developments
- 6.11 Becton-Dickinson(BD)Technologies
- 6.11.1 Becton-Dickinson(BD)Technologies Company Information
- 6.11.2 Becton-Dickinson(BD)Technologies Business Overview
- 6.11.3 Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio
- 6.11.5 Becton-Dickinson(BD)Technologies Recent Developments
7 North America by Country
- 7.1 North America Microneedle-mediated Drug Delivery Patch Sales by Country
- 7.1.1 North America Microneedle-mediated Drug Delivery Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026)
- 7.1.3 North America Microneedle-mediated Drug Delivery Patch Sales Forecast by Country (2027-2032)
- 7.2 North America Microneedle-mediated Drug Delivery Patch Market Size by Country
- 7.2.1 North America Microneedle-mediated Drug Delivery Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Microneedle-mediated Drug Delivery Patch Market Size by Country (2021-2026)
- 7.2.3 North America Microneedle-mediated Drug Delivery Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Microneedle-mediated Drug Delivery Patch Sales by Country
- 8.1.1 Europe Microneedle-mediated Drug Delivery Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026)
- 8.1.3 Europe Microneedle-mediated Drug Delivery Patch Sales Forecast by Country (2027-2032)
- 8.2 Europe Microneedle-mediated Drug Delivery Patch Market Size by Country
- 8.2.1 Europe Microneedle-mediated Drug Delivery Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Microneedle-mediated Drug Delivery Patch Market Size by Country (2021-2026)
- 8.2.3 Europe Microneedle-mediated Drug Delivery Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales by Country
- 9.1.1 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Microneedle-mediated Drug Delivery Patch Market Size by Country
- 9.2.1 Asia-Pacific Microneedle-mediated Drug Delivery Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Microneedle-mediated Drug Delivery Patch Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Microneedle-mediated Drug Delivery Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Microneedle-mediated Drug Delivery Patch Sales by Country
- 10.1.1 South America Microneedle-mediated Drug Delivery Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026)
- 10.1.3 South America Microneedle-mediated Drug Delivery Patch Sales Forecast by Country (2027-2032)
- 10.2 South America Microneedle-mediated Drug Delivery Patch Market Size by Country
- 10.2.1 South America Microneedle-mediated Drug Delivery Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Microneedle-mediated Drug Delivery Patch Market Size by Country (2021-2026)
- 10.2.3 South America Microneedle-mediated Drug Delivery Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales by Country
- 11.1.1 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Microneedle-mediated Drug Delivery Patch Market Size by Country
- 11.2.1 Middle East and Africa Microneedle-mediated Drug Delivery Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Microneedle-mediated Drug Delivery Patch Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Microneedle-mediated Drug Delivery Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Microneedle-mediated Drug Delivery Patch Value Chain Analysis
- 12.1.1 Microneedle-mediated Drug Delivery Patch Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Microneedle-mediated Drug Delivery Patch Production Mode & Process
- 12.2 Microneedle-mediated Drug Delivery Patch Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Microneedle-mediated Drug Delivery Patch Distributors
- 12.2.3 Microneedle-mediated Drug Delivery Patch Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst